EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML

Hong Zheng, Peng Zhao, Zhenya Tan, Wen-Mei Yu, Juwita Werner, Elliot Stieglitz, Christopher C Porter, Shanmuganathan Chandrakasan, Daniel S Wechsler, Simon Mendez-Ferrer, Cheng-Kui Qu

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Hong Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Aflac Cancer & Blood Disorders Center, Winship Cancer Institute, Children's Healthcare of Atlanta, Emory University School …. Hauptthemen laut MEDLINE: Immunity, Innate, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Leukemia, Myelomonocytic, Juvenile, Neoplastic Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Juvenile myelomonocytic leukemia (JMML) originates from mutated hematopoietic stem cells. The mechanism by which mutant stem cells are sustained, leading to leukemia development, remains elusive. By comprehensively examining transcriptomic profiles, cell compositions, developmental trajectories, and cell-cell interactions across various stages of tumor cell development in a mouse model of Ptpn11 mutation-associated JMML, we find that Ptpn11E76K/+ mutant stem cells exhibit de novo activation of the myeloid transcriptional program and markedly increased expression of innate immunity-associated antimicrobial peptides and pro-inflammatory proteins, particularly S100a9 and S100a8. Biological experiments confirm that S100a9/S100a8 confer a selective advantage to mutant stem cells through autocrine effects and facilitate immune evasion by recruiting and promoting immune-suppressive myeloid-derived suppressor cells in the microenvironment. Importantly, pharmacological inhibition of S100a9/S100a8 signaling effectively impede leukemia development from Ptpn11E76K/+ mutant stem cells. These findings collectively suggest that JMML-initiating cells exploit innate immune and inflammatory mechanisms to establish clonal dominance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateProtein Tyrosine Phosphatase, Non-Receptor Type 11Leukemia, Myelomonocytic, JuvenileNeoplastic Stem CellsImmune EvasionAnimalsMiceCalgranulin ACalgranulin BMutationSignal TransductionMice, Inbred C57BLHumans

Stichwörter der Autor:innen

CP: CancerCP: ImmunologyJMMLPTPN11S100a8S100a9hematopoietic stem cellinflammationinnate immunityleukemia-initiating cell

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 11Calgranulin ACalgranulin BPtpn11 protein, mouse

Autor:innen und Institutionen

  • Department of Pediatrics, Aflac Cancer & Blood Disorders Center, Winship Cancer Institute, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA; Department of Pathophysiology, Anhui Me…
  • Department of Pediatrics, Aflac Cancer & Blood Disorders Center, Winship Cancer Institute, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Pathophysiology, Anhui Medical University, Hefei, China.
  • Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Hematology, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Department of Pediatrics, Aflac Cancer & Blood Disorders Center, Winship Cancer Institute, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: cqu6@emory.edu.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health National Cancer Institute
  • National Institutes of Health
  • National Heart Lung and Blood Institute

Zitieren

APA

Zheng, H., Zhao, P., Tan, Z., Yu, W. M., Werner, J., Stieglitz, E., Porter, C. C., Chandrakasan, S., Wechsler, D. S., Mendez-Ferrer, S., & Qu, C. K. (2025). Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116087

Vancouver

Zheng H, Zhao P, Tan Z, Yu WM, Werner J, Stieglitz E, et al. Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116087

BibTeX
@article{Zheng2025,
  author = {Zheng, Hong and Zhao, Peng and Tan, Zhenya and Yu, Wen-Mei and Werner, Juwita and Stieglitz, Elliot and Porter, Christopher C and Chandrakasan, Shanmuganathan and Wechsler, Daniel S and Mendez-Ferrer, Simon and Qu, Cheng-Kui},
  title = {Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116087}
}
Kostenlos starten →